Skip to main content
. 2017 Aug 8;8(48):83872–83889. doi: 10.18632/oncotarget.20040

Figure 7. KX2-391 inhibits STAT3 and AKT phosphorylation in the injured peritoneum.

Figure 7

Peritoneal membrane was collected at 21 days after CG injury with or without administration of KX2-391(KX2) (A–E). (A) Peritoneum tissue lysates were subjected to immunoblot analysis with specific antibodies against p-STAT3, STAT3, p-AKT, AKT, or Tubulin. (B) Expression levels of p-STAT3 were quantified by densitometry and normalized with STAT3. (C) Expression levels of STAT3 were quantified by densitometry and normalized with Tubulin. (D) Expression level of p-AKT was quantified by densitometry and normalized with AKT. (E) Expression levels of AKT were quantified by densitometry and normalized with Tubulin. Data are means ± S.E.M. (n = 6). Bars with different letters (a–c) are significantly different from one another (P < 0.05).